NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » whitepapers » GBCAs for enhanced MRI of brain tumours

White Paper

GBCAs for enhanced MRI of brain tumours

March 4, 2015

Miles Kirchin from the division of global medical and regulatory affairs at Bracco Imaging reports the results of a study into the relative efficacy of non-ionic macrocyclic gadolinium-based contrast agents in brain tumour MRI.

Download to find out more.

Download White Paper